PFS Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51K | Hold |
227
| – | – | ﹤0.01% | 424 |
|
|
2025
Q1 | $3.38K | Hold |
227
| – | – | ﹤0.01% | 366 |
|
|
2024
Q4 | $3.01K | Hold |
227
| – | – | ﹤0.01% | 378 |
|
|
2024
Q3 | $3.23K | Hold |
227
| – | – | ﹤0.01% | 377 |
|
|
2024
Q2 | $2.94K | Hold |
227
| – | – | ﹤0.01% | 368 |
|
|
2024
Q1 | $3.15K | Hold |
227
| – | – | ﹤0.01% | 389 |
|
|
2023
Q4 | $3.24K | Hold |
227
| – | – | ﹤0.01% | 381 |
|
|
2023
Q3 | $3.51K | Hold |
227
| – | – | ﹤0.01% | 368 |
|
|
2023
Q2 | $3.57K | Hold |
227
| – | – | ﹤0.01% | 386 |
|
|
2023
Q1 | $3.74K | Hold |
227
| – | – | ﹤0.01% | 297 |
|
|
2022
Q4 | $3.54K | Hold |
227
| – | – | ﹤0.01% | 286 |
|
|
2022
Q3 | $2.95K | Hold |
227
| – | – | ﹤0.01% | 283 |
|
|
2022
Q2 | $3.19K | Hold |
227
| – | – | ﹤0.01% | 274 |
|
|
2022
Q1 | $3.25K | Hold |
227
| – | – | ﹤0.01% | 286 |
|
|
2021
Q4 | $3.1K | Buy |
+227
| New | +$3.1K | ﹤0.01% | 288 |
|